Логотип Артген
  • About
    • Company Strategy
    • Group Structure
    • Board of directors
    • Management
    • Career
    • Contacts
  • Development
    • Drugs
    • Medical devices
    • Medical services
  • Biotech valuation
  • Activity
    • Areas of activities
    • Research and development (R&D) stages
    • Ecosystem
    • Acceleration
    • Commercialization
  • Investor
    • Disclosure of information
  • News
En
RU CN
  • Главная
  • News
  • News

    News, press releases, events, publications

    Press releases
    All categories
    Portfolio
    Portfolio Histograft Betuvax Nextgen Gemabank Genetico Biotechnology Developments Genotarget
    • 05.12.2024
      Press releases
      The first patients received injections of a new drug for interstitial cystitis
    • 11.11.2024
      Press releases
      Gemabank’s cryostorage facility has been expanded to include 25,000 additional places
    • 07.11.2024
      Press releases
      Artgen Biotech’s shares are available for trading on the Saint Petersburg Stock Exchange
    • 06.11.2024
      Press releases
      The number of IVF cycles using PGT in Russia increased by 25%
    • 01.11.2024
      Press releases
      Artgen Biotech’s performance for 9 months of 2024 according to RAS
    • 30.10.2024
      Press releases
      Genetico’s performance for 9 months of 2024 according to RAS
    • 29.10.2024
      Press releases
      Gemabank’s results for 9 months of 2024 according to RAS
    1 2 3 4 … 12
    footer logotype
    Follow us
    • Telegram
    • VK
    • Interfax-CRCI
    Moscow, Gubkina street, 3, b.1
    • info@artgen.ru
    • +7 (495) 646-80-76
    ©2003-2025 Artgen biotech
      • About the Company
      • Company Strategy
      • Group Structure
      • Board of Directors
      • Management
      • Career
      • Contacts
      • Development Portfolio
      • Drugs
      • Medical Devices
      • Medical Services
      • Activity
      • Areas of activities
      • Research and development (R&D) stages
      • Ecosystem
      • Acceleration
      • Commercialization
      • Investors
      • Biotech Valuation
      • Disclosure of information
      • Contacts
    • About the Company
      • About
      • Company Strategy
      • Group Structure
      • Board of Directors
      • Management
      • Career
      • Contacts
    • Development Portfolio
      • Drugs
      • Medical Devices
      • Medical Services
    • Activity
      • Areas of activities
      • Research and development (R&D) stages
      • Ecosystem
      • Acceleration
      • Commercialization
    • Biotech Valuation
    • Investors
      • Disclosure of information